Skip to main content
. 2023 Jun 21;5(8):100685. doi: 10.1016/j.xkme.2023.100685

Table 2.

Cumulative Incidences for Outpatient Laboratory Measurements, Physician Follow-up Visits, Death, and Kidney Replacement Therapy.

Outcomes 3 mo 6 mo 12 mo
Primary outcome
Outpatient serum creatinine and urine protein measurement 25.4 [24.8, 25.9] 37.9 [37.3, 38.6] 54.5 [53.8, 55.2]
Secondary outcomes
Outpatient creatinine measurement only 64.1 [63.5, 64.7] 75.4 [74.9, 76.0] 85.6 [85.1, 86.0]
Outpatient urine protein measurement only 27.8 [27.2, 28.3] 40.3 [39.6, 40.9] 56.2 [55.5, 56.9]
Family physician visit 89.3 [88.9, 89.7] 93.0 [92.7, 93.3] 95.3 [95.0, 95.6]
Nephrology follow-up visit 4.6 [4.4, 4.9] 6.7 [6.4, 7.1] 8.9 [8.5, 9.3]
Internal medicine visit 28.0 [27.5, 28.6] 36.6 [36.0, 37.3] 45.2 [44.5, 45.8]
Cardiology visit 29.2 [28.6, 29.8] 36.3 [35.6, 36.9] 40.6 [40.0, 41.3]
Competing events
Death 4.6 [4.4, 4.9] 6.8 [6.5, 7.1] 9.2 [8.9, 9.6]
Kidney replacement therapya 0.09 [0.06, 0.13] 0.13 [0.09, 0.18] 0.17 [0.13, 0.23]
Rehospitalization 25.1 [24.6, 25.6] 30.6 [30.1, 31.1] 35.7 [35.2, 36.3]

Note: Cumulative incidence probabilities expressed as percentages and 95% confidence intervals.

a

Includes maintenance dialysis or kidney transplantation.